Skip to main content
. 2000 Jun 1;525(Pt 2):331–341. doi: 10.1111/j.1469-7793.2000.00331.x

Figure 5. The dopamine D2 receptor agonist quinpirole mimics the inhibitory effect of dopamine on GABAA IPSCs.

Figure 5

A, quinpirole (10 μM) reversibly reduces the amplitude of GABAA IPSCs. Each point represents the mean ±s.e.m. of 8 cells. B, the dopamine D1 receptor agonist SKF 82958 (10 μM) has no effect on the amplitude of GABAA IPSCs. Each point represents the mean ±s.e.m. of 8 cells.